Insider Transactions in Q1 2024 at Vera Therapeutics, Inc. (VERA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2024
|
Maha Katabi |
SELL
Open market or private sale
|
Indirect |
340,000
-10.85%
|
$13,600,000
$40.5 P/Share
|
|
Mar 22
2024
|
Maha Katabi |
SELL
Open market or private sale
|
Indirect |
413,450
-11.65%
|
$16,538,000
$40.51 P/Share
|
|
Mar 21
2024
|
Maha Katabi |
SELL
Open market or private sale
|
Indirect |
81,009
-0.56%
|
$3,564,396
$44.68 P/Share
|
|
Jan 30
2024
|
Maha Katabi |
BUY
Open market or private purchase
|
Indirect |
161,290
+4.26%
|
$4,999,990
$31.0 P/Share
|
|
Jan 16
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
78,750
+19.0%
|
-
|
|
Jan 16
2024
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
BUY
Grant, award, or other acquisition
|
Direct |
21,875
+27.71%
|
-
|
|
Jan 16
2024
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+25.02%
|
-
|
|
Jan 10
2024
|
Commodore Capital LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,050,000
-19.27%
|
$18,900,000
$18.0 P/Share
|